These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 33647257)

  • 1. Carvacrol alleviates liver fibrosis by inhibiting TRPM7 and modulating the MAPK signaling pathway.
    Cai S; Wu L; Yuan S; Liu G; Wang Y; Fang L; Xu D
    Eur J Pharmacol; 2021 May; 898():173982. PubMed ID: 33647257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propranolol prevents liver cirrhosis by inhibiting hepatic stellate cell activation mediated by the PDGFR/Akt pathway.
    Ding Q; Li Z; Liu B; Ling L; Tian X; Zhang C
    Hum Pathol; 2018 Jun; 76():37-46. PubMed ID: 29514109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Src family kinase member Fyn by Saracatinib attenuated liver fibrosis in vitro and in vivo.
    Du G; Wang J; Zhang T; Ding Q; Jia X; Zhao X; Dong J; Yang X; Lu S; Zhang C; Liu Z; Zeng Z; Safadi R; Qi R; Zhao X; Hong Z; Lu Y
    Cell Death Dis; 2020 Feb; 11(2):118. PubMed ID: 32051399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRPM7 channel regulates PDGF-BB-induced proliferation of hepatic stellate cells via PI3K and ERK pathways.
    Fang L; Zhan S; Huang C; Cheng X; Lv X; Si H; Li J
    Toxicol Appl Pharmacol; 2013 Nov; 272(3):713-25. PubMed ID: 23958495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antifibrotic effects of luteolin on hepatic stellate cells and liver fibrosis by targeting AKT/mTOR/p70S6K and TGFβ/Smad signalling pathways.
    Li J; Li X; Xu W; Wang S; Hu Z; Zhang Q; Deng X; Wang J; Zhang J; Guo C
    Liver Int; 2015 Apr; 35(4):1222-33. PubMed ID: 25040634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The inhibition of Hippo/Yap signaling pathway is required for magnesium isoglycyrrhizinate to ameliorate hepatic stellate cell inflammation and activation.
    Li L; Zhou J; Li Q; Xu J; Qi J; Bian H
    Biomed Pharmacother; 2018 Oct; 106():83-91. PubMed ID: 29957470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amygdalin inhibits TGFβ1-induced activation of hepatic stellate cells (HSCs) in vitro and CCl
    Wang R; Zhang D; Tang D; Sun K; Peng J; Zhu W; Yin S; Wu Y
    Int Immunopharmacol; 2021 Jan; 90():107151. PubMed ID: 33296784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SOD3 deficiency induces liver fibrosis by promoting hepatic stellate cell activation and epithelial-mesenchymal transition.
    Sun YL; Bai T; Zhou L; Zhu RT; Wang WJ; Liang RP; Li J; Zhang CX; Gou JJ
    J Cell Physiol; 2021 Jun; 236(6):4313-4329. PubMed ID: 33230845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silent information regulator 1 (SIRT1) ameliorates liver fibrosis via promoting activated stellate cell apoptosis and reversion.
    Wu Y; Liu X; Zhou Q; Huang C; Meng X; Xu F; Li J
    Toxicol Appl Pharmacol; 2015 Dec; 289(2):163-76. PubMed ID: 26435214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnesium isoglycyrrhizinate ameliorates liver fibrosis and hepatic stellate cell activation by regulating ferroptosis signaling pathway.
    Sui M; Jiang X; Chen J; Yang H; Zhu Y
    Biomed Pharmacother; 2018 Oct; 106():125-133. PubMed ID: 29957462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gambogic acid attenuates liver fibrosis by inhibiting the PI3K/AKT and MAPK signaling pathways via inhibiting HSP90.
    Yu Z; Jv Y; Cai L; Tian X; Huo X; Wang C; Zhang B; Sun C; Ning J; Feng L; Zhang H; Ma X
    Toxicol Appl Pharmacol; 2019 May; 371():63-73. PubMed ID: 30953615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aryl Hydrocarbon Receptor Signaling Prevents Activation of Hepatic Stellate Cells and Liver Fibrogenesis in Mice.
    Yan J; Tung HC; Li S; Niu Y; Garbacz WG; Lu P; Bi Y; Li Y; He J; Xu M; Ren S; Monga SP; Schwabe RF; Yang D; Xie W
    Gastroenterology; 2019 Sep; 157(3):793-806.e14. PubMed ID: 31170413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNMT1 controls LncRNA H19/ERK signal pathway in hepatic stellate cell activation and fibrosis.
    Yang JJ; She Q; Yang Y; Tao H; Li J
    Toxicol Lett; 2018 Oct; 295():325-334. PubMed ID: 30010033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NP603, a novel and potent inhibitor of FGFR1 tyrosine kinase, inhibits hepatic stellate cell proliferation and ameliorates hepatic fibrosis in rats.
    Lin N; Chen S; Pan W; Xu L; Hu K; Xu R
    Am J Physiol Cell Physiol; 2011 Aug; 301(2):C469-77. PubMed ID: 21543745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physcion 8-O-β-glucopyranoside ameliorates liver fibrosis through inflammation inhibition by regulating SIRT3-mediated NF-κB P65 nuclear expression.
    Chen C; Gu J; Wang J; Wu Y; Yang A; Chen T; Zhou T; Liu Z
    Int Immunopharmacol; 2021 Jan; 90():107206. PubMed ID: 33246826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alamandine attenuates hepatic fibrosis by regulating autophagy induced by NOX4-dependent ROS.
    Huang Y; Li Y; Lou A; Wang GZ; Hu Y; Zhang Y; Huang W; Wang J; Li Y; Zhu X; Chen T; Lin J; Meng Y; Li X
    Clin Sci (Lond); 2020 Apr; 134(7):853-869. PubMed ID: 32227122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flavonoid-rich Scabiosa comosa inflorescence extract attenuates CCl
    Ma Y; Yuan H; Jin R; Bao X; Wang H; Su X; Mu MGSL; Liang J; Zhang J; Wu X
    Biomed Pharmacother; 2018 Oct; 106():426-433. PubMed ID: 29990830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ferulic acid attenuates liver fibrosis and hepatic stellate cell activation via inhibition of TGF-β/Smad signaling pathway.
    Mu M; Zuo S; Wu RM; Deng KS; Lu S; Zhu JJ; Zou GL; Yang J; Cheng ML; Zhao XK
    Drug Des Devel Ther; 2018; 12():4107-4115. PubMed ID: 30584275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-fibrotic effects of the Masson pine pollen aqueous extract on hepatic fibrosis rat model.
    Cong T; Jin XY; Zhao L; Ma L; Li RS; Zhao P; Guo CJ
    Int J Clin Exp Pathol; 2015; 8(5):4651-61. PubMed ID: 26191155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A histone deacetylase inhibitor, largazole, decreases liver fibrosis and angiogenesis by inhibiting transforming growth factor-β and vascular endothelial growth factor signalling.
    Liu Y; Wang Z; Wang J; Lam W; Kwong S; Li F; Friedman SL; Zhou S; Ren Q; Xu Z; Wang X; Ji L; Tang S; Zhang H; Lui EL; Ye T
    Liver Int; 2013 Apr; 33(4):504-15. PubMed ID: 23279742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.